SCHEMBL6648461

SCHEMBL6648461

CCCCCNC(=O)c1cc(C(=O)O)cc(-c2ncco2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 2/20 0.46
KDM5A P29375 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
GLRA3 O75311 1/20 0.42
GLRB P48167 1/20 0.42
L3MBTL1 Q9Y468 3/20 0.41
KDM4E B2RXH2 4/20 0.41
ALDH1A1 P00352 3/20 0.41
LMNA P02545 1/20 0.41
XDH P47989 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
GPR84 Q9NQS5 2/20 0.38
MLYCD O95822 1/20 0.38
HCAR3 P49019 1/20 0.38
POLB P06746 2/20 0.38
HPGD P15428 2/20 0.38
CTDSP1 Q9GZU7 2/20 0.38
MEN1 O00255 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6649704 0.82 GLRA3 (0.41) GLRA3GLRBXDHHCAR3
SCHEMBL17373856 0.79 NAAA (0.68) NAAASMN1; SMN2L3MBTL1GPR84MLYCD
SCHEMBL17373956 0.79 NAAA (0.68) NAAASMN1; SMN2L3MBTL1GPR84MLYCD
SCHEMBL6645786 0.79 GLRA3 (0.44) SMN1; SMN2GLRA3GLRBHCAR3HTT
SCHEMBL6646087 0.79 GLRA3 (0.44) SMN1; SMN2GLRA3GLRBALDH1A1LMNA
SCHEMBL6650208 0.77 NAAA (0.46) NAAAKDM5ASMN1; SMN2L3MBTL1KDM4E
SCHEMBL3358061 0.77 LTA4H (0.40) KDM5AGLRA3GLRBALDH1A1HPGD
SCHEMBL20256885 0.76 GLRA3 (0.49) KDM5AGLRA3GLRBKDM4EALDH1A1
SCHEMBL475508 0.75 GLRA3 (0.70) GLRA3GLRBL3MBTL1KDM4EALDH1A1
SCHEMBL2207635 0.75 BACE1 (0.44) SMN1; SMN2GLRA3GLRBL3MBTL1MLYCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1453789-A2 N,N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES Elan Pharmaceuticals, Inc. (US) 2004-09-08 EP disclosed
WO-2003040096-A2 N, N'-SUBSTITUTED-1,3-DIAMINO-2-HYDROXYPROPANE DERIVATIVES ELAN PHARMACEUTICALS, INC. (US) 2003-05-15 WO disclosed